Left atrial thrombus and smoke resolution in patients with atrial fibrillation under chronic oral anticoagulation
- PMID: 35277775
- DOI: 10.1007/s10840-022-01169-1
Left atrial thrombus and smoke resolution in patients with atrial fibrillation under chronic oral anticoagulation
Abstract
Background: The study aimed to explore the resolution of left atrial and left atrial appendage (LAA) spontaneous echo-contrast or thrombus in patients with nonvalvular atrial fibrillation/flutter (AF/AFL) under chronic oral anticoagulation (OAC).
Methods: A single-center retrospective analysis of patients who underwent a transesophageal echocardiography (TOE) for an electrical cardioversion was conducted.
Results: Among 277 TOE performed, 73 cases (26%) of LAA echo-contrast or thrombus were detected, 53 patients with LAA/LA echo-contrast (19%) and 20 (7%) with a thrombus. All patients were under chronic anticoagulation with a VKA (65%) or with a NOAC (35%). The Echo-contrast Group maintained the same OAC strategy in 49 patients (93%). The Thrombus Group kept the same OAC strategy with a NOAC in 6 cases (30%) and changed the strategy in 14 patients (70%), titrating NOAC dose in 1 (5%) and the VKA dose in 4 (20%) and switching from NOAC to VKA in 5 (25%), from VKA to NOAC in 3 (15%), and from NOAC to NOAC in 1 (5%). Smoke resolution was observed in 4/40 cases (10%) of the smoke group and thrombus resolution in 8/15 (53%) of the thrombus group. Patients with thrombus resolution had a lower CHA2DS2-Vasc score (3.5 ± 2 vs 4 ± 1, p = 0.05), were more often under NOAC (37.5 vs 28%, p = 0.07), and had a longer anticoagulation time (7.5 vs 4 months, p = 0.08).
Conclusion (s): Changing OAC strategy is associated with thrombus resolution in more than 50% of chronically anticoagulated patients.
Keywords: Atrial fibrillation; Atrial thrombus; Oral anticoagulation; Transesophageal echocardiography.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Left atrial appendage thrombus in patients with atrial fibrillation who underwent oral anticoagulation.Cardiol J. 2024;31(3):461-471. doi: 10.5603/CJ.a2022.0054. Epub 2022 Jun 15. Cardiol J. 2024. PMID: 35703043 Free PMC article.
-
Clinical outcomes and thrombus resolution in patients with solid left atrial appendage thrombi: results of a single-center real-world registry.Clin Res Cardiol. 2021 Jan;110(1):72-83. doi: 10.1007/s00392-020-01651-8. Epub 2020 Apr 19. Clin Res Cardiol. 2021. PMID: 32307589
-
Left atrial thrombus in patients with atrial fibrillation and under oral anticoagulant therapy; 3-D transesophageal echocardiographic study.Int J Cardiovasc Imaging. 2020 Jun;36(6):1097-1103. doi: 10.1007/s10554-020-01811-x. Epub 2020 Mar 5. Int J Cardiovasc Imaging. 2020. PMID: 32140812
-
Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.J Am Coll Cardiol. 2021 Jun 15;77(23):2875-2886. doi: 10.1016/j.jacc.2021.04.036. J Am Coll Cardiol. 2021. PMID: 34112315
-
Diagnosis and Management of Left Atrium Appendage Thrombosis in Atrial Fibrillation Patients Undergoing Cardioversion.Medicina (Kaunas). 2019 Aug 21;55(9):511. doi: 10.3390/medicina55090511. Medicina (Kaunas). 2019. PMID: 31438560 Free PMC article. Review.
Cited by
-
Persistence of left atrial thrombus in patients with hypertrophic cardiomyopathy and atrial fibrillation.J Interv Card Electrophysiol. 2024 Jun;67(4):731-738. doi: 10.1007/s10840-023-01642-5. Epub 2023 Sep 16. J Interv Card Electrophysiol. 2024. PMID: 37715077
-
Discontinuation of Oral Anticoagulants in Atrial Fibrillation Patients: Impact of Treatment Strategy and on Patients' Health Status.J Clin Med. 2023 Dec 15;12(24):7712. doi: 10.3390/jcm12247712. J Clin Med. 2023. PMID: 38137780 Free PMC article.
-
The Prognostic Nutritional Index May Predict Left Atrial Appendage Thrombus or Dense Spontaneous Echo Contrast in Patients With Atrial Fibrillation.Front Cardiovasc Med. 2022 Apr 29;9:860624. doi: 10.3389/fcvm.2022.860624. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35571156 Free PMC article.
-
Long-Term Efficacy and Safety of Left Atrial Appendage Occlusion (LAAO) vs Direct Oral Anticoagulation (DOAC) in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis.Rev Cardiovasc Med. 2023 Feb 2;24(2):44. doi: 10.31083/j.rcm2402044. eCollection 2023 Feb. Rev Cardiovasc Med. 2023. PMID: 39077410 Free PMC article.
-
Heart Failure and the Non-Resolution of Atrial Thrombus Detected in Anticoagulated Patients with Non-Valvular Atrial Fibrillation.Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251324922. doi: 10.1177/10760296251324922. Epub 2025 Mar 18. Clin Appl Thromb Hemost. 2025. PMID: 40101245 Free PMC article.
References
-
- Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609–78. - DOI
-
- Al-Saady NM, Obel OA, Camm AJ. Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999;82:547–54. - DOI
-
- Watson T, Shantsila E, Lip GY. Mechanisms of thrombo-genesis in atrial fibrillation: Virchow’s triad revisited. Lancet. 2009;373:155–66. - DOI
-
- Al Saady NM, Obel OA, Camm AJ. Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999;82:547–54. - DOI
-
- Hohnloser SH, Basic E, Nabauer M. Uptake in anti-thrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database. Clin Res Cardiol. 2019;108:1042–52. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical